US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

1.10

-0.3000-21.43%

Post-market: 1.09-0.0100-0.91%19:53 EDT

Volume:889.31K

Turnover:1.06M

Market Cap:12.81M

PE:-2.76

High:1.41

Open:1.34

Low:1.03

Close:1.40

52wk High:79.92

52wk Low:0.3750

Shares:11.64M

Float Shares:8.20M

Volume Ratio:1.28

T/O Rate:10.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3985

EPS(LYR):77.74

ROE:--

ROA:-129.01%

PB:-0.81

PE(LYR):0.01

Loading ...

Overview Company News Filings

AEON Biopharma Inc. Held Annual Stockholders Meeting

AEON Thana Sinsap (Thailand) Faces Earnings Hit From Likely Higher Credit Costs -- Market Talk

AEON Biopharma Inc. Files Amendment to 10-Q Quarterly Report

AEON Financial Service Challenges Vietnam Subsidiary Acquisition Over Accounting Irregularities

MT Newswires Live

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Mall to Cancel Treasury Stock Ahead of Share Exchange with Aeon Co.

MT Newswires Live

Director Jost Fischer Reports Acquisition of AEON Biopharma Inc. Common Shares

AEON Biopharma Inc. Unveils Corporate Presentation on Developing ABP-450 as Botox® Biosimilar

AEON Credit Service Issues MYR400 Million Islamic Debt

MT Newswires Live

AEON Biopharma Q1 EPS $2.28 Up From $(227.87) YoY

AEON Biopharma Reports First Quarter 2025 Financial Results with Focus on Advancing ABP-450 Development

AEON Biopharma Says NYSE American Accepts Plan to Regain Compliance

MT Newswires Live

AEON Credit Service (M) Issues MYR100 Million Islamic Debt

MT Newswires Live

Aeon Biopharma Names Robert Bancroft CEO

MT Newswires Live

AEON Biopharma Appoints Rob Bancroft as CEO

Press Release: AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Press Release: AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AEON/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AEON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AEON\",,,,,undefined,":{"symbol":"AEON","market":"US","secType":"STK","nameCN":"AEON Biopharma","latestPrice":1.1,"timestamp":1760731200000,"preClose":1.4,"halted":0,"volume":889305,"hourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.1,"latestTime":"19:53 EDT","volume":14712,"amount":16215.7548,"timestamp":1760745235465},"delay":0,"floatShares":8196336,"shares":11643786,"eps":-0.398501,"marketStatus":"Market Closed","change":-0.3,"latestTime":"10-17 16:00:00 EDT","open":1.34,"high":1.4145,"low":1.03,"amount":1056167.6982735,"amplitude":0.274643,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.398501,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.4,"preHourTrading":{"tag":"盘前","latestPrice":1.32,"preClose":1.4,"latestTime":"09:19 EDT","volume":26510,"amount":35251.889881999996,"timestamp":1760707180160},"postHourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.1,"latestTime":"19:53 EDT","volume":14712,"amount":16215.7548,"timestamp":1760745235465},"volumeRatio":1.277049339135563},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AEON\",,,,,undefined,":{"symbol":"AEON","floatShares":8196336,"roa":"-129.01%","roe":"--","lyrEps":77.735213,"volumeRatio":1.277049339135563,"shares":11643786,"dividePrice":0,"high":1.4145,"amplitude":0.274643,"preClose":1.4,"low":1.03,"week52Low":0.375,"pbRate":"-0.81","week52High":79.92,"institutionHeld":0,"latestPrice":1.1,"eps":-0.398501,"divideRate":0,"volume":889305,"delay":0,"ttmEps":-0.398501,"open":1.34,"prevYearClose":38.88,"prevWeekClose":1.13,"prevMonthClose":0.8086,"prevQuarterClose":0.8086,"fiveDayClose":1.13,"twentyDayClose":0.7629,"sixtyDayClose":0.812},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AEON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-26","symbol":"AEON","defaultRemindTime":1740580200000,"type":"split","dateTimestamp":1740546000000,"forFactor":72,"toFactor":1,"ratio":72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AEON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AEON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747800000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AEON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AEON","date":"2025-10-17","current":-2.760344,"percent":0.08972,"low":-24.301569,"twenty":-6.330272,"median":-0.385481,"eighty":0.35062,"high":2.629651,"avg":-2.987562,"sd":4.755209,"marketCap":16301300},"quantilePoints":[{"date":"2023-07-28","current":-3.37691,"twenty":-21.448776,"median":-11.461912,"eighty":-3.316366,"marketCap":177476894},{"date":"2023-08-04","current":-5.443476,"twenty":-11.148476,"median":-5.443476,"eighty":-3.386305,"marketCap":286087324},{"date":"2023-08-11","current":-5.188976,"twenty":-5.600418,"median":-5.478823,"eighty":-4.466171,"marketCap":272711813},{"date":"2023-08-18","current":-3.068141,"twenty":-5.560829,"median":-5.188976,"eighty":-3.316366,"marketCap":161249219},{"date":"2023-08-25","current":-2.01912,"twenty":-5.541035,"median":-4.414871,"eighty":-2.956443,"marketCap":157533799},{"date":"2023-09-01","current":-2.542949,"twenty":-5.522654,"median":-3.37691,"eighty":-2.403896,"marketCap":198403417},{"date":"2023-09-08","current":-2.342942,"twenty":-5.485892,"median":-3.110558,"eighty":-2.227699,"marketCap":182798654},{"date":"2023-09-15","current":-2.652477,"twenty":-5.347332,"median":-2.95503,"eighty":-2.273416,"marketCap":206948882},{"date":"2023-09-22","current":-2.914391,"twenty":-5.197459,"median":-2.95725,"eighty":-2.302941,"marketCap":227383691},{"date":"2023-09-29","current":-2.838198,"twenty":-5.186148,"median":-2.9407,"eighty":-2.401992,"marketCap":221439020},{"date":"2023-10-06","current":-3.00487,"twenty":-5.094245,"median":-2.923915,"eighty":-2.50009,"marketCap":234442989},{"date":"2023-10-13","current":-2.904867,"twenty":-4.524447,"median":-2.928677,"eighty":-2.525805,"marketCap":226640607},{"date":"2023-10-20","current":-2.795339,"twenty":-3.677221,"median":-2.928677,"eighty":-2.550568,"marketCap":218095142},{"date":"2023-10-27","current":-2.242938,"twenty":-3.487452,"median":-2.923915,"eighty":-2.537234,"marketCap":174996272},{"date":"2023-11-03","current":-2.404849,"twenty":-3.380042,"median":-2.905206,"eighty":-2.454375,"marketCap":187628699},{"date":"2023-11-10","current":-2.100076,"twenty":-3.255821,"median":-2.857246,"eighty":-2.276273,"marketCap":163850013},{"date":"2023-11-17","current":-6.097255,"twenty":-3.380042,"median":-2.847722,"eighty":-2.265796,"marketCap":175021716},{"date":"2023-11-24","current":-6.653905,"twenty":-5.050414,"median":-2.883437,"eighty":-2.274368,"marketCap":191000344},{"date":"2023-12-01","current":-7.365899,"twenty":-5.471754,"median":-2.914391,"eighty":-2.276273,"marketCap":211438124},{"date":"2023-12-08","current":-7.870767,"twenty":-5.600418,"median":-2.931058,"eighty":-2.307702,"marketCap":225930368},{"date":"2023-12-15","current":-7.314117,"twenty":-6.190462,"median":-2.95725,"eighty":-2.337227,"marketCap":209951740},{"date":"2023-12-22","current":-7.314117,"twenty":-6.653905,"median":-2.962099,"eighty":-2.367705,"marketCap":209951740},{"date":"2023-12-29","current":-9.087629,"twenty":-6.767824,"median":-2.969199,"eighty":-2.380086,"marketCap":260860392},{"date":"2024-01-05","current":-10.019694,"twenty":-7.14065,"median":-3.000108,"eighty":-2.41723,"marketCap":287615304},{"date":"2024-01-12","current":-9.126465,"twenty":-7.314117,"median":-3.048411,"eighty":-2.471518,"marketCap":261975180},{"date":"2024-01-19","current":-9.255918,"twenty":-7.573024,"median":-3.07392,"eighty":-2.490566,"marketCap":265691140},{"date":"2024-01-26","current":-10.744633,"twenty":-7.831931,"median":-3.110558,"eighty":-2.514376,"marketCap":308424680},{"date":"2024-02-02","current":-9.242973,"twenty":-8.414471,"median":-3.301229,"eighty":-2.514376,"marketCap":265319544},{"date":"2024-02-09","current":-11.650806,"twenty":-9.126465,"median":-3.866989,"eighty":-2.542949,"marketCap":334436400},{"date":"2024-02-16","current":-12.699379,"twenty":-9.255918,"median":-5.185441,"eighty":-2.561997,"marketCap":364535676},{"date":"2024-02-23","current":-13.527881,"twenty":-9.341358,"median":-5.323296,"eighty":-2.565807,"marketCap":388317820},{"date":"2024-03-01","current":-15.404955,"twenty":-9.623566,"median":-5.535379,"eighty":-2.635333,"marketCap":442199240},{"date":"2024-03-08","current":-15.806261,"twenty":-10.537507,"median":-5.606073,"eighty":-2.663906,"marketCap":453718716},{"date":"2024-03-15","current":-18.770744,"twenty":-11.073444,"median":-6.08431,"eighty":-2.70105,"marketCap":538814200},{"date":"2024-03-22","current":-14.110421,"twenty":-11.650806,"median":-6.369108,"eighty":-2.709622,"marketCap":405039640},{"date":"2024-03-28","current":-15.767425,"twenty":-12.002919,"median":-6.653905,"eighty":-2.718194,"marketCap":452603928},{"date":"2024-04-05","current":-8.500224,"twenty":-11.974754,"median":-7.119937,"eighty":-2.73248,"marketCap":311380189},{"date":"2024-04-12","current":-8.77875,"twenty":-11.932361,"median":-7.229973,"eighty":-2.761052,"marketCap":321583181},{"date":"2024-04-19","current":-6.746537,"twenty":-11.754369,"median":-7.197609,"eighty":-2.78772,"marketCap":247139131},{"date":"2024-04-26","current":-4.384217,"twenty":-11.650806,"median":-7.113764,"eighty":-2.818197,"marketCap":160602646},{"date":"2024-05-03","current":-3.557269,"twenty":-11.635272,"median":-6.938703,"eighty":-2.836293,"marketCap":130309865},{"date":"2024-05-10","current":-1.75746,"twenty":-11.609381,"median":-6.653905,"eighty":-2.73248,"marketCap":64379278},{"date":"2024-05-17","current":-0.424594,"twenty":-11.389311,"median":-6.330272,"eighty":-2.661049,"marketCap":58174047},{"date":"2024-05-24","current":-0.478376,"twenty":-11.117458,"median":-5.909548,"eighty":-2.53152,"marketCap":65542759},{"date":"2024-05-31","current":-0.40761,"twenty":-11.024252,"median":-5.606073,"eighty":-2.47628,"marketCap":55847085},{"date":"2024-06-07","current":-0.468287,"twenty":-10.933635,"median":-5.535379,"eighty":-2.297226,"marketCap":64160470},{"date":"2024-06-14","current":-0.388336,"twenty":-10.796414,"median":-5.443476,"eighty":-2.248653,"marketCap":53206243},{"date":"2024-06-21","current":-0.362637,"twenty":-10.744633,"median":-5.203115,"eighty":-2.200079,"marketCap":49685242},{"date":"2024-06-28","current":-0.302673,"twenty":-10.64107,"median":-5.188976,"eighty":-2.19246,"marketCap":41469572},{"date":"2024-07-05","current":-0.274276,"twenty":-10.431356,"median":-4.962753,"eighty":-2.107695,"marketCap":37578865},{"date":"2024-07-12","current":-0.302673,"twenty":-10.175038,"median":-4.621481,"eighty":-1.959118,"marketCap":41469572},{"date":"2024-07-15","current":-0.399757,"twenty":-10.136202,"median":-4.435796,"eighty":-1.957213,"marketCap":54771133},{"date":"2024-08-02","current":-0.328372,"twenty":-10.097366,"median":-4.410006,"eighty":-1.94007,"marketCap":44990573},{"date":"2024-08-09","current":-0.283199,"twenty":-9.794445,"median":-4.116006,"eighty":-1.791339,"marketCap":38801435},{"date":"2024-08-16","current":0.976891,"twenty":-9.628744,"median":-3.823294,"eighty":-1.725699,"marketCap":41498349},{"date":"2024-08-23","current":0.902462,"twenty":-9.587319,"median":-3.392568,"eighty":-0.494794,"marketCap":38336570},{"date":"2024-08-30","current":0.882459,"twenty":-9.465633,"median":-3.198546,"eighty":-0.467793,"marketCap":37486842},{"date":"2024-09-06","current":0.760487,"twenty":-9.387961,"median":-3.102954,"eighty":-0.447239,"marketCap":32305477},{"date":"2024-09-13","current":0.689406,"twenty":-9.356893,"median":-3.071539,"eighty":-0.436887,"marketCap":29285978},{"date":"2024-09-20","current":0.622419,"twenty":-9.328413,"median":-3.016776,"eighty":-0.426081,"marketCap":26440377},{"date":"2024-09-27","current":0.798539,"twenty":-9.299933,"median":-2.976298,"eighty":-0.398044,"marketCap":33921936},{"date":"2024-10-04","current":1.032714,"twenty":-9.263686,"median":-2.95725,"eighty":-0.370632,"marketCap":43869684},{"date":"2024-10-11","current":1.02341,"twenty":-9.25074,"median":-2.933439,"eighty":-0.302673,"marketCap":43474461},{"date":"2024-10-18","current":1.004803,"twenty":-9.222261,"median":-2.919153,"eighty":-0.296962,"marketCap":42684017},{"date":"2024-10-25","current":-0.131948,"twenty":-9.191192,"median":-2.904867,"eighty":-0.28642,"marketCap":40312682},{"date":"2024-10-31","current":-0.119232,"twenty":-9.178247,"median":-2.857246,"eighty":-0.27525,"marketCap":36427646},{"date":"2024-11-08","current":-0.104122,"twenty":-9.123876,"median":-2.835817,"eighty":-0.130913,"marketCap":31811449},{"date":"2024-11-15","current":-0.079143,"twenty":-9.108342,"median":-2.776291,"eighty":-0.126778,"marketCap":24179705},{"date":"2024-11-22","current":-0.072313,"twenty":-9.072095,"median":-2.716765,"eighty":-0.11348,"marketCap":22092931},{"date":"2024-11-29","current":1.589186,"twenty":-9.009957,"median":-2.688192,"eighty":-0.104122,"marketCap":21740059},{"date":"2024-12-06","current":1.876402,"twenty":-8.820014,"median":-2.566759,"eighty":-0.079828,"marketCap":25669179},{"date":"2024-12-13","current":2.074502,"twenty":-8.77875,"median":-2.528663,"eighty":-0.072908,"marketCap":28379192},{"date":"2024-12-20","current":1.897731,"twenty":-8.77875,"median":-2.490566,"eighty":-0.068574,"marketCap":25960965},{"date":"2024-12-27","current":1.753101,"twenty":-8.687971,"median":-2.404849,"eighty":0.64112,"marketCap":23982415},{"date":"2025-01-03","current":1.606424,"twenty":-8.566245,"median":-2.328655,"eighty":0.670743,"marketCap":21975887},{"date":"2025-01-10","current":0.555441,"twenty":-8.465923,"median":-2.276273,"eighty":0.673831,"marketCap":7598428},{"date":"2025-01-17","current":0.499341,"twenty":-8.386877,"median":-2.242938,"eighty":0.661104,"marketCap":6830991},{"date":"2025-01-24","current":0.373995,"twenty":-8.306286,"median":-2.214365,"eighty":0.653875,"marketCap":5116248},{"date":"2025-01-31","current":0.355003,"twenty":-8.119633,"median":-2.190555,"eighty":0.644804,"marketCap":4856439},{"date":"2025-02-07","current":0.409057,"twenty":-7.992936,"median":-2.119124,"eighty":0.64112,"marketCap":5595897},{"date":"2025-02-14","current":0.759955,"twenty":-7.945195,"median":-1.990548,"eighty":0.662835,"marketCap":10396190},{"date":"2025-02-21","current":0.627255,"twenty":-7.870767,"median":-1.957213,"eighty":0.672268,"marketCap":8580855},{"date":"2025-02-28","current":0.069013,"twenty":-7.844876,"median":-1.894137,"eighty":0.672268,"marketCap":944098},{"date":"2025-03-07","current":0.057646,"twenty":-7.840012,"median":-1.799809,"eighty":0.664565,"marketCap":788599},{"date":"2025-03-14","current":0.048796,"twenty":-7.831931,"median":-1.757333,"eighty":0.655913,"marketCap":667533},{"date":"2025-03-21","current":0.058864,"twenty":-7.818986,"median":-1.725699,"eighty":0.645725,"marketCap":805260},{"date":"2025-03-28","current":0.160481,"twenty":-7.78015,"median":-0.533573,"eighty":0.64112,"marketCap":6740993},{"date":"2025-04-04","current":0.133274,"twenty":-7.664643,"median":-0.479709,"eighty":0.64112,"marketCap":5598184},{"date":"2025-04-11","current":0.102632,"twenty":-7.624806,"median":-0.46767,"eighty":0.637193,"marketCap":4311075},{"date":"2025-04-17","current":0.100275,"twenty":-7.58338,"median":-0.455731,"eighty":0.629243,"marketCap":4212067},{"date":"2025-04-25","current":0.115346,"twenty":-7.407324,"median":-0.445444,"eighty":0.624131,"marketCap":4845088},{"date":"2025-05-02","current":0.109578,"twenty":-7.340008,"median":-0.437837,"eighty":0.622605,"marketCap":4602834},{"date":"2025-05-09","current":0.114844,"twenty":-7.326085,"median":-0.431167,"eighty":0.615352,"marketCap":4824023},{"date":"2025-05-16","current":0.032963,"twenty":-7.316138,"median":-0.424594,"eighty":0.56707,"marketCap":5574676},{"date":"2025-05-23","current":0.0367,"twenty":-7.314117,"median":-0.399757,"eighty":0.544922,"marketCap":6206646},{"date":"2025-05-30","current":0.04027,"twenty":-7.283048,"median":-0.390626,"eighty":0.516521,"marketCap":6810353},{"date":"2025-06-06","current":0.048786,"twenty":-7.2235,"median":-0.372631,"eighty":0.469714,"marketCap":8250656},{"date":"2025-06-13","current":0.059623,"twenty":-7.16654,"median":-0.314095,"eighty":0.427172,"marketCap":10083256},{"date":"2025-06-20","current":0.051474,"twenty":-7.135472,"median":-0.302673,"eighty":0.41081,"marketCap":8705132},{"date":"2025-06-27","current":0.050992,"twenty":-7.114998,"median":-0.29839,"eighty":0.40707,"marketCap":8623733},{"date":"2025-07-03","current":0.055993,"twenty":-7.086958,"median":-0.296962,"eighty":0.40219,"marketCap":9469375},{"date":"2025-07-11","current":0.05749,"twenty":-6.991286,"median":-0.291252,"eighty":0.394592,"marketCap":9722615},{"date":"2025-07-18","current":0.052075,"twenty":-6.90027,"median":-0.280145,"eighty":0.391817,"marketCap":8806880},{"date":"2025-07-25","current":0.054281,"twenty":-6.728011,"median":-0.274276,"eighty":0.38054,"marketCap":9179958},{"date":"2025-08-01","current":0.048619,"twenty":-6.653905,"median":-0.131301,"eighty":0.379429,"marketCap":8222393},{"date":"2025-08-08","current":0.047683,"twenty":-6.604713,"median":-0.129361,"eighty":0.377735,"marketCap":8064118},{"date":"2025-08-15","current":-5.551438,"twenty":-6.39241,"median":-0.129361,"eighty":0.377209,"marketCap":9082153},{"date":"2025-08-22","current":-4.910888,"twenty":-6.283669,"median":-0.131948,"eighty":0.375631,"marketCap":8034212},{"date":"2025-08-29","current":-5.53578,"twenty":-6.094666,"median":-0.274276,"eighty":0.373411,"marketCap":9056536},{"date":"2025-09-05","current":-5.463896,"twenty":-6.08431,"median":-0.280145,"eighty":0.371073,"marketCap":8938934},{"date":"2025-09-12","current":-5.508735,"twenty":-5.764955,"median":-0.291252,"eighty":0.366982,"marketCap":9012290},{"date":"2025-09-19","current":-5.409094,"twenty":-5.734786,"median":-0.296962,"eighty":0.365814,"marketCap":8849277},{"date":"2025-09-26","current":-5.542186,"twenty":-5.634351,"median":-0.299818,"eighty":0.364061,"marketCap":9067016},{"date":"2025-10-03","current":-5.8041,"twenty":-5.764955,"median":-0.302673,"eighty":0.355003,"marketCap":9495507},{"date":"2025-10-10","current":-7.330745,"twenty":-5.992706,"median":-0.328372,"eighty":0.352081,"marketCap":11993099},{"date":"2025-10-17","current":-9.96412,"twenty":-6.330272,"median":-0.385481,"eighty":0.35062,"marketCap":16301300}],"updateTime":1760845558521},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AEON\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543763713","title":"AEON Biopharma Inc. Held Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543763713","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543763713?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:05","pubTimestamp":1749845152,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. held its Annual Meeting of Stockholders on June 13, 2025. At the meeting, stockholders elected Jost Fischer and Eric Carter as Class II directors of the board. Additionally, the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2025, was ratified. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL411Hyc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"2543714545","title":"AEON Thana Sinsap (Thailand) Faces Earnings Hit From Likely Higher Credit Costs -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2543714545","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543714545?lang=en_us&edition=fundamental","pubTime":"2025-06-13 13:24","pubTimestamp":1749792240,"startTime":"0","endTime":"0","summary":"0524 GMT - AEON Thana Sinsap  faces an earnings hit from likely higher credit costs, UOB Kay Hian's Thanawat Thangchadakorn says in a research report. The brokerage reckons many uncertainties loom, which is why the financial services provider hasn't provided clear financial targets for 2026. Given Thailand's worsening economic outlook, the company will probably have to increase credit costs on quarter in 1Q 2026 as a precaution. The brokerage cuts its earnings forecasts for AEON Thana Sinsap by 2.6% for 2026, 2.2% for 2027 and 2.3% for 2028. It lowers the stock's target price to THB140.00 from THB152.00, with an unchanged buy rating. Shares are 2.0% lower at THB100.00. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON"],"gpt_icon":0},{"id":"2542532014","title":"AEON Biopharma Inc. Files Amendment to 10-Q Quarterly Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2542532014","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542532014?lang=en_us&edition=fundamental","pubTime":"2025-06-12 04:07","pubTimestamp":1749672476,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. filed an amendment to the 10-Q annual report for the financial year ending March 31, 2025. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL8bNGCV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139"],"gpt_icon":0},{"id":"2542087551","title":"AEON Financial Service Challenges Vietnam Subsidiary Acquisition Over Accounting Irregularities","url":"https://stock-news.laohu8.com/highlight/detail?id=2542087551","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542087551?lang=en_us&edition=fundamental","pubTime":"2025-06-09 10:20","pubTimestamp":1749435616,"startTime":"0","endTime":"0","summary":"AEON Financial Service Co  has contested the validity of its equity transfer agreement with Southeast Asia Commercial Joint Stock Bank  regarding Post and Telecommunication Finance Company Limited  in Vietnam, according to a Friday filing on the Tokyo Stock Exchange.The company uncovered inappropriate accounting transactions before acquiring PTF, which became its consolidated subsidiary in February 2025.AEON notified SeABank that the equity transfer agreement is invalid and plans to pursue a full investigation, legal action, compensation for damages, and reimbursement of expenses related to the acquisition.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTF","AEON","BK4139"],"gpt_icon":0},{"id":"2538911035","title":"AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711","url":"https://stock-news.laohu8.com/highlight/detail?id=2538911035","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538911035?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:05","pubTimestamp":1748030700,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May  23, 2025  (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin compl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/05/23/3087716/0/en/AEON-Biopharma-Reports-Inducement-Grants-Under-NYSE-American-LLC-Company-Guide-Section-711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","AEON","AFG","BK4139","NYSE","BK4117"],"gpt_icon":0},{"id":"2537907940","title":"AEON Mall to Cancel Treasury Stock Ahead of Share Exchange with Aeon Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2537907940","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537907940?lang=en_us&edition=fundamental","pubTime":"2025-05-23 15:25","pubTimestamp":1747985149,"startTime":"0","endTime":"0","summary":"AEON Mall  board approved the cancellation of all treasury stock effective July 1, in line with a previously announced share exchange that will make the company a wholly owned subsidiary of Aeon Co , according to a Thursday filing on the Tokyo Stock Exchange.The cancellation is required under the share exchange agreement signed in April, which involves Aeon acquiring all Aeon Mall shares it does not already own.The cancellation will include shares held as of the record date, including any additional shares acquired through exercise of share purchase demand, the filing said.As of February 28, Aeon Mall held 4,896 treasury shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["US12M.BOND","US30Y.BOND","US5Y.BOND","US10Y.BOND","BK4139","US2Y.BOND","US3Y.BOND","US6M.BOND","US7Y.BOND","AEON"],"gpt_icon":0},{"id":"2537135951","title":"Director Jost Fischer Reports Acquisition of AEON Biopharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537135951","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537135951?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:50","pubTimestamp":1747860655,"startTime":"0","endTime":"0","summary":"Jost Fischer, a Director at AEON Biopharma Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL512Xb8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"2537939027","title":"AEON Biopharma Inc. Unveils Corporate Presentation on Developing ABP-450 as Botox® Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2537939027","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537939027?lang=en_us&edition=fundamental","pubTime":"2025-05-21 22:17","pubTimestamp":1747837072,"startTime":"0","endTime":"0","summary":"AEON Biopharma Inc. has released a corporate presentation detailing its development of ABP-450, a 900kD botulinum toxin being developed as a biosimilar to Botox. The presentation highlights AEON's strategic efforts to address persistent cost-related barriers in the market, such as high out-of-pocket costs for patients and product margin concerns for physicians. The company is progressing with its Comparative Analytical Assessment  studies, which began in Q4 2024, and is targeting an FDA BPD Type 2a meeting in the second half of 2025. The presentation outlines AEON's readiness to reshape access in a market currently dominated by Botox. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL5QjpJm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"2537670843","title":"AEON Credit Service Issues MYR400 Million Islamic Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2537670843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537670843?lang=en_us&edition=fundamental","pubTime":"2025-05-21 13:27","pubTimestamp":1747805254,"startTime":"0","endTime":"0","summary":"AEON Credit Service   issued 400 million ringgit in senior sukuk under its sukuk program on Tuesday.The issuance has a tenure of 7 years, according to a Thursday Malaysian bourse filing.Proceeds will be used for consumer financing based on Shariah principles and to refinance existing loans or sukuk.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4220","AEON","BK4588","BK4585","BK4103"],"gpt_icon":0},{"id":"2535000111","title":"AEON Biopharma Q1 EPS $2.28 Up From $(227.87) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2535000111","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535000111?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:34","pubTimestamp":1747254880,"startTime":"0","endTime":"0","summary":"AEON Biopharma Q1 EPS $2.28 Up From $(227.87) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45421685/aeon-biopharma-q1-eps-2-28-up-from-227-87-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON"],"gpt_icon":0},{"id":"2535079070","title":"AEON Biopharma Reports First Quarter 2025 Financial Results with Focus on Advancing ABP-450 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2535079070","media":"Reuters","labels":["executive","dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535079070?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:15","pubTimestamp":1747253734,"startTime":"0","endTime":"0","summary":"AEON Biopharma, Inc. has announced its financial results for the first quarter ended March 31, 2025. The company, focused on developing a botulinum toxin complex for therapeutic treatments, is actively advancing the biosimilar development program for ABP-450 using BOTOX as a reference product. AEON is pursuing the 351 regulatory pathway to potentially access the U.S. market with a single FDA approval covering all current and future therapeutic indications of BOTOX. The company recently appointed Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft, who brings over 25 years of leadership experience in the life sciences industry, was also appointed to AEON's Board of Directors. Prior to AEON, he successfully led the launch of Daxxify for Revance Therapeutics. Additionally, the NYSE American LLC has accepted AEON's plan to regain compliance with continued listing standards related to minimum market capitalization and stockholders' equity, granting ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL9c6Zpx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","BK4112","LU0256863902.USD","LU0738911758.USD","LU0661504455.SGD","LU0689626769.HKD","IE00BQXX3C00.GBP","LU1153585028.USD","LU1974910355.USD","LU0949170772.SGD","LU0648001328.SGD","AEON","SGXZ23171101.USD","BK4139","LU0130102774.USD","LU0154245756.USD","LU0011850046.USD","LU1917777945.USD","GB00BDT5M118.USD","LU0124676726.USD","LU0256863811.USD","BK4585","LU0154236417.USD","IE00BQXX3D17.EUR","LU0390134368.USD","LU2023250843.SGD","LU2237957811.SGD","LU2237957902.USD","LU0130517989.USD","BK4588","LU0154245673.USD","LU0417517546.SGD","LU0477156953.USD","IE00BQXX3F31.USD","LU0980610538.SGD","SG9999004303.SGD","LU1201861249.SGD","LU2106854487.HKD","ICE"],"gpt_icon":0},{"id":"2530160204","title":"AEON Biopharma Says NYSE American Accepts Plan to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2530160204","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530160204?lang=en_us&edition=fundamental","pubTime":"2025-04-26 04:32","pubTimestamp":1745613152,"startTime":"0","endTime":"0","summary":"AEON Biopharma  said late Friday that the NYSE American has accepted its plan to regain compliance with listing standards relating to minimum market capitalization and stockholders' equity.The company has until Aug. 3 to regain compliance with the continued listing standards by implementing its plan.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","AEON","BK4139","NYSE","BK4117","AFG"],"gpt_icon":0},{"id":"2530964922","title":"AEON Credit Service (M) Issues MYR100 Million Islamic Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2530964922","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530964922?lang=en_us&edition=fundamental","pubTime":"2025-04-25 14:33","pubTimestamp":1745562810,"startTime":"0","endTime":"0","summary":"AEON Credit Service   issued 100 million ringgit in senior sukuk under its sukuk program on Thursday.The issuance has a tenure of 176 days, according to a Thursday Malaysian bourse filing.Proceeds will be used for consumer financing based on Shariah principles and to refinance existing loans or sukuk.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","AEON","BK4103","BK4220","BK4588"],"gpt_icon":0},{"id":"2529567733","title":"Aeon Biopharma Names Robert Bancroft CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2529567733","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529567733?lang=en_us&edition=fundamental","pubTime":"2025-04-22 05:40","pubTimestamp":1745271604,"startTime":"0","endTime":"0","summary":"Aeon Biopharma  said late Monday it appointed Robert Bancroft as chief executive officer, starting April 29.Bancroft most recently served as general manager of the therapeutics business at Revance Therapeutics.Jost Fisher will step down as interim president and CEO but will remain chairman of the board, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AEON"],"gpt_icon":0},{"id":"2529588453","title":"AEON Biopharma Appoints Rob Bancroft as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2529588453","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529588453?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:25","pubTimestamp":1745267100,"startTime":"0","endTime":"0","summary":"AEON Biopharma named Rob Bancroft as its new chief executive.The Irvine, Calif. biopharmaceutical company, which is working on developing an alternative to Botox, said Monday Bancroft brings experience in the therapeutic toxin industry with 25 years of leadership under his belt.Bancroft is set to step into the role on April 29. He previously worked as general manager of the therapeutics business at Revance Therapeutics.Bancroft succeeds Marc Forth, who stepped down on April 4 to pursue another opportunity.Forth received total compensation of about $4 million as chief executive in 2023, according to a separate filing with the Securities and Exchange Commission.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON"],"gpt_icon":0},{"id":"2529330508","title":"Press Release: AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711","url":"https://stock-news.laohu8.com/highlight/detail?id=2529330508","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529330508?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:10","pubTimestamp":1745266200,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., April 21, 2025  -- AEON Biopharma, Inc.  , a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, today announced that, in connection with the appointment of Rob Bancroft as President and Chief Executive Officer, the Company's Compensation Committee of the Board of Directors has approved the grant of inducement awards.The stock option and RSUs vest over four years, 25% on each annual anniversary of the vesting commencement date, which will be Mr. Bancroft's employment start date. The awards are subject to the terms and conditions of the Inducement Plan and the terms and conditions of the stock option agreement or RSU agreement, as applicable, covering the grant. The awards are being granted as an inducement material to Mr. Bancroft entering into employment with the Company in accordance with Section 711 of NYSE American LLC Company Guide.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4139","AFG","AEON","BK4117","NYSE"],"gpt_icon":0},{"id":"2529833330","title":"Press Release: AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529833330","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529833330?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:05","pubTimestamp":1745265900,"startTime":"0","endTime":"0","summary":"-- Former CEO, Marc Forth, to remain as a member of the Company's Board of Directors --. Mr. Bancroft brings over 25 years of leadership experience in the life sciences industry, spanning biopharmaceuticals, medical devices, and healthcare technology. Prior to joining AEON, he served as General Manager of the Therapeutics business at Revance Therapeutics, where he led the launch of Daxxify in cervical dystonia with a novel strategy that prioritized expert endorsement, payer coverage, and reimbursement infrastructure ahead of broader investment - driving strong early adoption and differentiated positioning in the $3B botulinum toxin therapeutics market. Previously, Mr. Bancroft was President of Smith & Nephew's Biotherapeutics division, following the $782M acquisition of Healthpoint Biotherapeutics, where he orchestrated a strategic turnaround that led to four consecutive years of accelerating growth. He also served as Chief Executive Officer of QMENTA, a neuroimaging SaaS startup, wher","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BK4139","BK4232","R","BK4022"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}]}}